Last reviewed · How we verify
NCT03538366
Fecal Microbiota Transplantation for Chronic Pouchitis
NA trial testing Donor FMT in Ulcerative Colitis in 10 participants. Completed in 1 May 2019.
1 May 2019
Quick facts
| Lead sponsor | Aalborg University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 May 2018 |
| Primary completion | 1 May 2019 |
| Estimated completion | 1 May 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Donor FMT
Conditions studied
- Ulcerative Colitis — all drugs for Ulcerative Colitis →
- Pouchitis — all drugs for Pouchitis →
Sponsor
Aalborg University Hospital
Who can join
18 and older, any sex, with Ulcerative Colitis or Pouchitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with chronic pouchitis are treated with fecal transplant from several unrelated, healthy donors. The treatment consists of enemas of 100 mL fecal suspension, applied for 14 consecutive days.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H, Jain D, Tang DWT, Wong SH, et al · · 2024 · cited 53× · PMID 37935653 · DOI 10.5217/ir.2023.00080 -
Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study.
Kousgaard SJ, Michaelsen TY, Nielsen HL, Kirk KF, et al · · 2020 · cited 21× · PMID 32285709 · DOI 10.1080/00365521.2020.1748221
Verify or expand the search:
- PubMed search for NCT03538366
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Donor FMT
Trials testing the same drug.
- NCT04759001 — FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae · Phase 1, PHASE2 · recruiting
- NCT03808389 — Fecal Microbiota Transplantation for Parkinson's Disease · NA · completed
- NCT04040712 — Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors · NA · completed
Other recruiting trials for Ulcerative Colitis
Currently open trials in the same condition.
- NCT07185009 — A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti · Phase 3 · recruiting
- NCT07265570 — Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) · Phase 2 · recruiting
- NCT07223424 — Patient Preference for Subcutaneous vs. Intravenous Immune Therapy · Phase 2 · recruiting
- NCT06405087 — A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD · Phase 3 · recruiting
- NCT07184996 — An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ · Phase 3 · recruiting
Other Aalborg University Hospital trials
Trials by the same sponsor.
- NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
- NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
- NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
- NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
- NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03538366 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
- Last refreshed: 19 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03538366.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing